AV
Ashwani Verma UBS Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
43
Avg Return
Past Year
Past Year
4.5%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
80%
Neutral
20%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Technology
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
Technology
Scientific & Technical Instruments
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $705 |
46%
upside
| 2 | +8.4% |
0
%
| 5 Mar ‘26 9 hours ago |
|
|
|
Buy
Maintained
| $251 |
56%
upside
| 2 | -3.2% |
0
%
| 24 Feb ‘26 9 days ago |
|
|
|
Neutral
Downgraded
| $46 |
63%
upside
| 1 | +16% |
0
%
| 11 Feb ‘26 22 days ago |
|
|
|
Buy
Maintained
| $178 |
37%
upside
| 1 | +5.1% |
0
%
| 23 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $215 |
51%
upside
| 1 | -18% |
0
%
| 6 Jan ‘26 1 month ago |
|
|
|
Buy
Maintained
| $40 |
80%
upside
| 1 | +11% |
0
%
| 6 Jan ‘26 1 month ago |
|
|
|
Neutral
Initiated
| $95 |
176%
upside
| 1 | – |
–
| 16 Dec ‘25 2 months ago |
|
|
|
Buy
Maintained
| $48 |
173%
upside
| 1 | -30% |
0
%
| 8 Dec ‘25 2 months ago |
|